Home » Solexa Taps New England Biolabs to Supply Reagents, Manufacture SBS Polymerase

Solexa Taps New England Biolabs to Supply Reagents, Manufacture SBS Polymerase

Aug 01, 2006
NEW YORK (GenomeWeb News) — Solexa today said it has tapped New England Biolabs to provide it with “certain key enzymes and other reagents” for its genome-analysis system, and to manufacture its sequencing-by-synthesis polymerase.
 
Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

More to Go Around

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

Call for Ban

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

To Worry or Not?

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

This Week in PLOS

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.

What's Popular?

In Clinical Sequencing

  1. Families Declining Enrollment in BabySeq Cite Lack of Interest in Research, Logistical Challenges

  2. FDA Mulls Guidelines for NGS-Based Infectious Disease Diagnostics

    Premium

  3. Survey Finds QC Best Practices in Clinical Genomics Still Developing

  4. Bristol-Myers Squibb to Use Natera's Cell-Free DNA Assay in Immunotherapy Study

  5. Yale to Launch Large-Scale Genomic Medicine Project

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.